We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: POWDER UNIFORMITY DATA MUST PRECEDE CONTROL METHODS
FDA: POWDER UNIFORMITY DATA MUST PRECEDE CONTROL METHODS
January 5, 2004
Drugmakers should assess the powder mix uniformity of their raw materials and correlate this data with stratified in-process dosage unit data and finished product samples before implementing manufacturing control methods on their products, the FDA recommended in a new draft guidance.